SCHEMBL18748834

SCHEMBL18748834

COC(=O)Nc1cccc(F)c1COc1cc(C)c(C)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
NPC1 O15118 3/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
KMT2A Q03164 2/20 0.41
SLC22A12 Q96S37 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
POLB P06746 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.37
GUCY1B2 O75343 2/20 0.37
GUCY1A2 P33402 2/20 0.37
GUCY1A1 Q02108 2/20 0.37
GUCY1B1 Q02153 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18748936 0.93 RAB9A (0.42) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18514810 0.91 RAB9A (0.39) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18748988 0.91 ALDH1A1 (0.45) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18748836 0.90 MAPT (0.48) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18749012 0.90 RAB9A (0.40) RAB9ANPSR1MAPTNPC1KMT2A
SCHEMBL18748860 0.90 RAB9A (0.40) RAB9ANPSR1MAPTNPC1KMT2A
SCHEMBL18748847 0.90 ALDH1A1 (0.43) RAB9ANPC1KMT2ASMN1; SMN2KDM4E
SCHEMBL18749220 0.90 RAB9A (0.42) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18748796 0.89 MRGPRX4 (0.47) RAB9ANPSR1MAPTNPC1MRGPRX4
SCHEMBL18748938 0.88 MAPT (0.44) RAB9ANPSR1MAPTNPC1MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10040768-B2 Carbamate compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-08-07 US disclosed
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 US disclosed
US-20180014539-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-18 US disclosed
US-20180002291-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-04 US disclosed
US-20180002294-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-04 US disclosed
US-20170360044-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-21 US disclosed
US-20170342032-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-30 US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10040768-B2 Carbamate compound and use thereof C9, C5, C1S RAB9A 759/4885NPSR1 2694/4885MAPT 3358/4885
US-20180014539-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S RAB9A 758/4885NPSR1 2778/4885MAPT 3347/4885
US-20170360044-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S RAB9A 676/4885NPSR1 2764/4885MAPT 3184/4885
US-20170342032-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S RAB9A 684/4885NPSR1 2767/4885MAPT 3169/4885
US-20180002291-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S RAB9A 649/4885NPSR1 2837/4885MAPT 3308/4885
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 RAB9A 143/4885NPSR1 1960/4885MAPT 3329/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 RAB9A 338/4885NPSR1 2148/4885MAPT 2998/4885
US-20180002294-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S RAB9A 759/4885NPSR1 2694/4885MAPT 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.